NPPB and cardiomyopathy: In general, in cardiomyopathy patients with structural heart disease and/or clinical symptoms, elevated plasma levels of NT-proBNP, BNP and cTns are associated with a higher risk of cardiovascular events, HF and death [75,80,81,82,83,84].